-
Product Insights
Discoidin Domain Containing Receptor 2 – Drugs In Development, 2023
Global Markets Direct’s Discoidin Domain Containing Receptor 2 provides in depth analysis on Discoidin Domain Containing Receptor 2 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Discoidin...
-
Product Insights
Endothelial PAS Domain Containing Protein 1 – Drugs In Development, 2023
Global Markets Direct’s Endothelial PAS Domain Containing Protein 1 provides in depth analysis on Endothelial PAS Domain Containing Protein 1 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved...
-
Product Insights
T Cell Immunoreceptor With Ig And ITIM Domains – Drugs In Development, 2023
Global Markets Direct’s T Cell Immunoreceptor With Ig And ITIM Domains provides in depth analysis on T Cell Immunoreceptor With Ig And ITIM Domains targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview...
-
Product Insights
Epithelial Discoidin Domain Containing Receptor 1 – Drugs In Development, 2023
Global Markets Direct’s Epithelial Discoidin Domain Containing Receptor 1 provides in depth analysis on Epithelial Discoidin Domain Containing Receptor 1 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved...
-
Product Insights
NACHT LRR And PYD Domains Containing Protein 3 – Drugs In Development, 2023
Global Markets Direct’s NACHT LRR And PYD Domains Containing Protein 3 provides in depth analysis on NACHT LRR And PYD Domains Containing Protein 3 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview...
-
Product Insights
Nucleotide Binding Oligomerization Domain Containing Protein 2 – Drugs In Development, 2023
Global Markets Direct’s Nucleotide Binding Oligomerization Domain Containing Protein 2 provides in depth analysis on Nucleotide Binding Oligomerization Domain Containing Protein 2 targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
V Type Immunoglobulin Domain Containing Suppressor of T Cell Activation – Drugs In Development, 2023
Global Markets Direct’s V Type Immunoglobulin Domain Containing Suppressor of T Cell Activation provides in depth analysis on V Type Immunoglobulin Domain Containing Suppressor of T Cell Activation targeted pipeline therapeutics. The report provides comprehensive information complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Thematic Analysis
NewUkraine Conflict Impact – Thematic Intelligence
Reasons to buy the ‘Ukraine Conflict Impact’ thematic intelligence report: Find out who are the leading players in the Ukraine war impact theme, and where they sit in the value chain. Gain in-depth insight into the main trends shaping the Ukraine War Impact theme over the next 12 to 24 months; classified into three categories: technology trends, macroeconomic trends, and regulatory trends. Identify the leading companies and the key disruptor companies making their mark within the Ukraine War Impact theme....
-
Analyst Opinions
NewNew Prescription – Generative AI Meets Healthcare (Vol. 2)
Generative Artificial Intelligence (AI) in Healthcare Report Overview GenAI is generating considerable buzz within the healthcare sector, from news updates to deal negotiations and company filings primarily to drive down costs and optimize administrative workflows, promising better healthcare. From accelerating R&D to easing administrative tasks and creating personalized patient experiences, genAI innovations have now proliferated across all the major healthcare application areas. The ’Generative Artificial Intelligence (AI) in Healthcare’ research report is a compendium of the latest real-world innovations in...
-
Analyst Opinions
NewMobile World Congress (MWC) 2024 – Startups Race for Digital Change
Mobile World Congress (MWC) 2024 Report Overview MWC (Mobile World Congress) is a premier global event for the mobile technology industry, while 4YFN (4 Years from Now) is its associated platform focusing on connecting startups with investors and partners to drive innovation. With over 40 companies in attendance, AI startups took center stage at MWC 2024, signaling robust investor and market interest in AI as the key driver for future innovation. Beyond AI, fintech, digitalization, IoT, digital media, and health...